Institution
Jikei University School of Medicine
Also known as: Tōkyō jikei kai ika daigaku · 東京慈恵会医科大学
- 4running trials
- 1closed trial
- 1researcher
- 31,256publications (OpenAlex)
Researchers
Running trials
Recruiting
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Active, not recruiting
Recruiting
International REgistry of COnservative or Radical Treatment of Localized Kidney Tumors
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Kidney cancer1 recruiting
- Ovarian cancer1 recruiting
Closed trials
Registry name variants (4)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Jikei University School of Medicine
Minato-ku, Tokyo, 105-8461
2 trials
NCT06580314Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Contact: Nozomu Yanaihara (principal investigator)
Jikei University School of Medicine
Tokyo, 105-8461
1 trial
NCT05363657International REgistry of COnservative or Radical Treatment of Localized Kidney Tumors
Contact: Shin Egawa
The Jikei University School of Medicine
Tokyo, 105-8461
1 trial
The Jikei University School of Medicine
Tokyo, 105-8461
1 trial
Conditions
Diseases this institution publishes on or runs trials for.
- Bladder cancer60 works · 0 trials
- Prostate cancer49 works · 0 trials
- IgA nephropathy27 works · 0 trials
- Kidney cancer23 works · 1 trial
- Aortic aneurysm17 works · 0 trials
- Brain aneurysm15 works · 0 trials
- Chronic rhinosinusitis with nasal polyps12 works · 0 trials
- Meningioma11 works · 0 trials
- Hydrocephalus7 works · 0 trials
- Nephrotic syndrome6 works · 0 trials
- Retinitis pigmentosa6 works · 0 trials
- Polycystic kidney disease5 works · 0 trials
- Neurofibromatosis type 15 works · 0 trials
- Fabry disease3 works · 0 trials
Institution data: ROR 039ygjf22 (CC0-1.0)Updated 15 Nov 2026